-
Je něco špatně v tomto záznamu ?
Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences
MM. Jelen, Z. Chen, BJ. Kocjan, L. Hošnjak, FJ. Burt, PK. Chan, D. Chouhy, CE. Combrinck, C. Estrade, A. Fiander, SM. Garland, AA. Giri, JV. González, A. Gröning, S. Hibbitts, TN. Luk, K. Marinic, T. Matsukura, A. Neumann, A. Oštrbenk, MA....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 1967 do Před 6 měsíci
Freely Accessible Science Journals
od 1967 do Před 6 měsíci
PubMed Central
od 1967 do Před 1 rokem
Europe PubMed Central
od 1967 do Před 6 měsíci
Open Access Digital Library
od 1967-02-01
Open Access Digital Library
od 1967-02-01
PubMed
27030261
DOI
10.1128/jvi.03149-15
Knihovny.cz E-zdroje
- MeSH
- fylogeneze MeSH
- genetická variace * MeSH
- genom virový * MeSH
- genomika MeSH
- genotyp MeSH
- infekce papilomavirem virologie MeSH
- jednonukleotidový polymorfismus MeSH
- lidé MeSH
- lidský papilomavirus 11 klasifikace genetika izolace a purifikace MeSH
- molekulární evoluce MeSH
- otevřené čtecí rámce MeSH
- pravděpodobnostní funkce MeSH
- sekvenční seřazení MeSH
- vysoce účinné nukleotidové sekvenování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
UNLABELLED: Human papillomavirus 11 (HPV11) is an etiological agent of anogenital warts and laryngeal papillomas and is included in the 4-valent and 9-valent prophylactic HPV vaccines. We established the largest collection of globally circulating HPV11 isolates to date and examined the genomic diversity of 433 isolates and 78 complete genomes (CGs) from six continents. The genomic variation within the 2,800-bp E5a-E5b-L1-upstream regulatory region was initially studied in 181/207 (87.4%) HPV11 isolates collected for this study. Of these, the CGs of 30 HPV11 variants containing unique single nucleotide polymorphisms (SNPs), indels (insertions or deletions), or amino acid changes were fully sequenced. A maximum likelihood tree based on the global alignment of 78 HPV11 CGs (30 CGs from our study and 48 CGs from GenBank) revealed two HPV11 lineages (lineages A and B) and four sublineages (sublineages A1, A2, A3, and A4). HPV11 (sub)lineage-specific SNPs within the CG were identified, as well as the 208-bp representative region for CG-based phylogenetic clustering within the partial E2 open reading frame and noncoding region 2. Globally, sublineage A2 was the most prevalent, followed by sublineages A1, A3, and A4 and lineage B. IMPORTANCE: This collaborative international study defined the global heterogeneity of HPV11 and established the largest collection of globally circulating HPV11 genomic variants to date. Thirty novel complete HPV11 genomes were determined and submitted to the available sequence repositories. Global phylogenetic analysis revealed two HPV11 variant lineages and four sublineages. The HPV11 (sub)lineage-specific SNPs and the representative region identified within the partial genomic region E2/noncoding region 2 (NCR2) will enable the simpler identification and comparison of HPV11 variants worldwide. This study provides an important knowledge base for HPV11 for future studies in HPV epidemiology, evolution, pathogenicity, prevention, and molecular assay development.
DNA Laboratories Sdn Bhd UKM MTDC Technology Centre Universiti Kebangsaan Malaysia Bangi Malaysia
Institute of Pathology Faculty of Medicine University of Ljubljana Ljubljana Slovenia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17024094
- 003
- CZ-PrNML
- 005
- 20170828115037.0
- 007
- ta
- 008
- 170720s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/JVI.03149-15 $2 doi
- 035 __
- $a (PubMed)27030261
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jelen, Mateja M $u Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 245 10
- $a Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences / $c MM. Jelen, Z. Chen, BJ. Kocjan, L. Hošnjak, FJ. Burt, PK. Chan, D. Chouhy, CE. Combrinck, C. Estrade, A. Fiander, SM. Garland, AA. Giri, JV. González, A. Gröning, S. Hibbitts, TN. Luk, K. Marinic, T. Matsukura, A. Neumann, A. Oštrbenk, MA. Picconi, M. Sagadin, R. Sahli, RY. Seedat, K. Seme, A. Severini, JL. Sinchi, J. Smahelova, SN. Tabrizi, R. Tachezy, S. Tohme Faybush, V. Uloza, I. Uloziene, YW. Wong, S. Židovec Lepej, RD. Burk, M. Poljak,
- 520 9_
- $a UNLABELLED: Human papillomavirus 11 (HPV11) is an etiological agent of anogenital warts and laryngeal papillomas and is included in the 4-valent and 9-valent prophylactic HPV vaccines. We established the largest collection of globally circulating HPV11 isolates to date and examined the genomic diversity of 433 isolates and 78 complete genomes (CGs) from six continents. The genomic variation within the 2,800-bp E5a-E5b-L1-upstream regulatory region was initially studied in 181/207 (87.4%) HPV11 isolates collected for this study. Of these, the CGs of 30 HPV11 variants containing unique single nucleotide polymorphisms (SNPs), indels (insertions or deletions), or amino acid changes were fully sequenced. A maximum likelihood tree based on the global alignment of 78 HPV11 CGs (30 CGs from our study and 48 CGs from GenBank) revealed two HPV11 lineages (lineages A and B) and four sublineages (sublineages A1, A2, A3, and A4). HPV11 (sub)lineage-specific SNPs within the CG were identified, as well as the 208-bp representative region for CG-based phylogenetic clustering within the partial E2 open reading frame and noncoding region 2. Globally, sublineage A2 was the most prevalent, followed by sublineages A1, A3, and A4 and lineage B. IMPORTANCE: This collaborative international study defined the global heterogeneity of HPV11 and established the largest collection of globally circulating HPV11 genomic variants to date. Thirty novel complete HPV11 genomes were determined and submitted to the available sequence repositories. Global phylogenetic analysis revealed two HPV11 variant lineages and four sublineages. The HPV11 (sub)lineage-specific SNPs and the representative region identified within the partial genomic region E2/noncoding region 2 (NCR2) will enable the simpler identification and comparison of HPV11 variants worldwide. This study provides an important knowledge base for HPV11 for future studies in HPV epidemiology, evolution, pathogenicity, prevention, and molecular assay development.
- 650 _2
- $a molekulární evoluce $7 D019143
- 650 12
- $a genetická variace $7 D014644
- 650 12
- $a genom virový $7 D016679
- 650 _2
- $a genomika $7 D023281
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a lidský papilomavirus 11 $x klasifikace $x genetika $x izolace a purifikace $7 D052140
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a pravděpodobnostní funkce $7 D016013
- 650 _2
- $a otevřené čtecí rámce $7 D016366
- 650 _2
- $a infekce papilomavirem $x virologie $7 D030361
- 650 _2
- $a fylogeneze $7 D010802
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a sekvenční seřazení $7 D016415
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Chen, Zigui $u Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
- 700 1_
- $a Kocjan, Boštjan J $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Hošnjak, Lea $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Burt, Felicity J $u Department of Medical Microbiology and Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
- 700 1_
- $a Chan, Paul K S $u Department of Microbiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
- 700 1_
- $a Chouhy, Diego $u Human Virology Group, National Council of Scientific and Technical Research, Institute of Molecular and Cell Biology of Rosario, Rosario, Argentina.
- 700 1_
- $a Combrinck, Catharina E $u Department of Medical Microbiology and Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
- 700 1_
- $a Estrade, Christine $u Institute of Microbiology, Lausanne University Hospital (CHUV), and University of Lausanne, Lausanne, Switzerland.
- 700 1_
- $a Fiander, Alison $u Department of Obstetrics and Gynaecology, Cardiff University School of Medicine, Institute of Cancer and Genetics, Cardiff, United Kingdom.
- 700 1_
- $a Garland, Suzanne M $u Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
- 700 1_
- $a Giri, Adriana A $u Human Virology Group, National Council of Scientific and Technical Research, Institute of Molecular and Cell Biology of Rosario, Rosario, Argentina.
- 700 1_
- $a González, Joaquín Víctor $u Oncogenic Viruses Service, National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
- 700 1_
- $a Gröning, Arndt $u Medizinisches Versorgungszentrum wagnerstibbe für Laboratoriumsmedizin und Pathologie GmbH, Hannover, Germany.
- 700 1_
- $a Hibbitts, Sam $u Department of Obstetrics and Gynaecology, Cardiff University School of Medicine, Institute of Cancer and Genetics, Cardiff, United Kingdom.
- 700 1_
- $a Luk, Tommy N M $u Dermatology Research Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China Department of Health, Social Hygiene Service, Centre for Health Protection, Hong Kong Special Administrative Region, China.
- 700 1_
- $a Marinic, Karina $u Histocompatibility and Molecular Genetics Laboratory, Dr. Julio C. Perrando Hospital, Resistencia, Chaco, Argentina.
- 700 1_
- $a Matsukura, Toshihiko $u Momate Memorial Laboratory, Tokyo, Japan.
- 700 1_
- $a Neumann, Anna $u Medizinisches Versorgungszentrum wagnerstibbe für Laboratoriumsmedizin und Pathologie GmbH, Hannover, Germany.
- 700 1_
- $a Oštrbenk, Anja $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Picconi, Maria Alejandra $u Oncogenic Viruses Service, National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbrán, Buenos Aires, Argentina.
- 700 1_
- $a Sagadin, Martin $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Sahli, Roland $u Institute of Microbiology, Lausanne University Hospital (CHUV), and University of Lausanne, Lausanne, Switzerland.
- 700 1_
- $a Seedat, Riaz Y $u Department of Otorhinolaryngology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
- 700 1_
- $a Seme, Katja $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- 700 1_
- $a Severini, Alberto $u Viral Exanthemata and STD Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
- 700 1_
- $a Sinchi, Jessica L $u Histocompatibility and Molecular Genetics Laboratory, Dr. Julio C. Perrando Hospital, Resistencia, Chaco, Argentina.
- 700 1_
- $a Smahelova, Jana $u Department of Experimental Virology, National Reference Laboratory for Papillomaviruses, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Tabrizi, Sepehr N $u Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville, Victoria, Australia Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
- 700 1_
- $a Tachezy, Ruth $u Department of Experimental Virology, National Reference Laboratory for Papillomaviruses, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Tohme Faybush, Sarah $u Viral Exanthemata and STD Section, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
- 700 1_
- $a Uloza, Virgilijus $u Department of Otolaryngology, Lithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania.
- 700 1_
- $a Uloziene, Ingrida $u Department of Otolaryngology, Lithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania.
- 700 1_
- $a Wong, Yong Wee $u DNA Laboratories Sdn. Bhd., UKM-MTDC Technology Centre, Universiti Kebangsaan Malaysia, Bangi, Malaysia.
- 700 1_
- $a Židovec Lepej, Snježana $u Department of Molecular Diagnostics, University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia.
- 700 1_
- $a Burk, Robert D $u Departments of Pediatrics, Microbiology and Immunology, Epidemiology and Population Health, Obstetrics and Gynecology, and Women's Health, Albert Einstein College of Medicine, New York, New York, USA.
- 700 1_
- $a Poljak, Mario $u Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia mario.poljak@mf.uni-lj.si.
- 773 0_
- $w MED00003048 $t Journal of virology $x 1098-5514 $g Roč. 90, č. 11 (2016), s. 5503-13
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27030261 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170828115623 $b ABA008
- 999 __
- $a ok $b bmc $g 1239775 $s 985007
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 90 $c 11 $d 5503-13 $e 20160512 $i 1098-5514 $m Journal of virology $n J Virol $x MED00003048
- LZP __
- $a Pubmed-20170720
